Plus, news about XOMA Royalty, Turnstone Biologics, CorMedix, the Novo Nordisk Foundation, Achieve Life Sciences and Cidara Therapeutics:
BioCryst sells Orladeyo business in Europe: The company will get $250 million upfront ...
↧